Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Martínez-Salamanca, Juan I; Linares, Estefania; González, Javier; Bertini, Roberto; Carballido, Joaquín A; Chromecki, Thomas; Ciancio, Gaetano; Daneshmand, Sia; Evans, Christopher P; Gontero, Paolo; Haferkamp, Axel; Hohenfellner, Markus; Huang, William C; Koppie, Theresa M; Master, Viraj A; Matloob, Rayan; McKiernan, James M; Mlynarczyk, Carrie M; Montorsi, Francesco; Nguyen, Hao G; ... (2014). Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Current urology reports, 15(5), p. 404. Current Science 10.1007/s11934-014-0404-7

Full text not available from this repository. (Request a copy)

Renal cell carcinoma (RCC) extension into the renal vein or the inferior vena cava occurs in 4%-10% of all kidney cancer cases. This entity shows a wide range of different clinical and surgical scenarios, making natural history and oncological outcomes variable and poorly characterized. Infrequency and variability make it necessary to share the experience from different institutions to properly analyze surgical outcomes in this setting. The International Renal Cell Carcinoma-Venous Tumor Thrombus Consortium was created to answer the questions generated by competing results from different retrospective studies in RCC with venous extension on current controversial topics. The aim of this article is to summarize the experience gained from the analysis of the world's largest cohort of patients in this unique setting to date.

Item Type:

Journal Article (Review Article)


04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Spahn, Martin


600 Technology > 610 Medicine & health




Current Science




Katharina Morgenegg

Date Deposited:

26 Feb 2015 16:54

Last Modified:

05 Nov 2015 10:38

Publisher DOI:


PubMed ID:




Actions (login required)

Edit item Edit item
Provide Feedback